E5555
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for E5555, covering 2013-05-13 to 2016-12-05. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Tolerability of E5555 and Its Effects on Markers of Intravascular Inflammation in Subjects With Coronary Artery Disease [Phase 2]